[Use of difluocortolone valerate chlorquinaldol cream in dermatoses with aggregate complications].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002750:Chlorquinaldol / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005448:Fluocortolone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011244:Pregnadienediols / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D009824:Ointments; D011244:Pregnadienediols; D005448:Fluocortolone; D002750:Chlorquinaldol
Empleo del valerianato de diflucortolona-clorquinaldol, crema, en dermatósis que cursan con complicaciones agregadas.